|
SKAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.87381271294407E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23970000043272E-07 |
| Normal-vs-Stage2 |
1.339550E-02 |
| Normal-vs-Stage3 |
4.562200E-02 |
| Normal-vs-Stage4 |
8.946100E-02 |
| Stage1-vs-Stage2 |
8.060200E-01 |
| Stage1-vs-Stage3 |
1.654830E-01 |
| Stage1-vs-Stage4 |
1.298180E-01 |
| Stage2-vs-Stage3 |
2.422200E-01 |
| Stage2-vs-Stage4 |
2.212200E-01 |
| Stage3-vs-Stage4 |
8.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87110005267499E-09 |
| Normal-vs-AfricanAmerican |
2.35530000000095E-05 |
| Normal-vs-Asian |
2.885200E-01 |
| Caucasian-vs-AfricanAmerican |
8.968200E-01 |
| Caucasian-vs-Asian |
9.973400E-01 |
| AfricanAmerican-vs-Asian |
9.645800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.27189974902842E-10 |
| Normal-vs-Female |
1.45419999997287E-06 |
| Male-vs-Female |
4.176800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.014500E-02 |
| Normal-vs-Extreme_Weight |
5.89469999999759E-05 |
| Normal-vs-Obese |
1.33749999964294E-07 |
| Normal-vs-Extreme_Obese |
2.790000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.294000E-01 |
| Normal_Weight-vs-Obese |
2.010000E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.783000E-01 |
| Extreme_Weight-vs-Obese |
4.392800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.144600E-01 |
| Obese-vs-Extreme_Obese |
6.145600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.495560E-03 |
| Normal-vs-Age(41-60Yrs) |
6.70219990617227E-10 |
| Normal-vs-Age(61-80Yrs) |
3.48869999999835E-06 |
| Normal-vs-Age(81-100Yrs) |
1.907160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.830000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.347200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.206400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.355700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.271000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.358400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6965318039297E-12 |
| Normal-VS-Type2 PRCC |
1.763960E-02 |
| Normal-VS-KIRP CIMP |
2.622200E-02 |
| Normal-VS-Unclassified PRCC |
7.789100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.023700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.453000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.946200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.243000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.970000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.468200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.598100E-02 |
| Normal-vs-N1 |
9.717800E-02 |
| Normal-vs-N2 |
6.448400E-02 |
| N0-vs-N1 |
8.107200E-01 |
| N0-vs-N2 |
9.823200E-01 |
| N1-vs-N2 |
9.125800E-01 |
|
|
